Russian cancer vaccine ready for use

Russia's Federal Medical and Biological Agency recently announced that its anti-cancer vaccine has passed preclinical trials and is currently awaiting approval for use from the Russian Ministry of Health.

According to the Russian Federal Medical and Biological Agency, studies have demonstrated the safety of the vaccine, including repeated use, and high efficacy in terms of reducing the size and significantly slowing the growth of tumors (up to 60-80%).

The new vaccine is expected to be used for colorectal cancer. The Russian Federal Medical and Biological Agency is also finalizing the development of a vaccine against glioblastoma - one of the most malignant tumors, with barrier tumors located behind the blood-brain barrier in the brain structure, and special types of melanoma./.

(Vietnam+)

Source: https://www.vietnamplus.vn/vaccine-chong-ung-thu-cua-nga-da-san-sang-duoc-su-dung-post1060357.vnp